Table 1.
Baseline demographic and clinical characteristics of the study population (n = 604)*.
| Demographic data | |
| Age at enrollment (Yrs) | 65 ± 10 |
| Gender (Male %) | 82 |
| Race (Caucasian vs. Other %) | 89 |
| Institution A, (%) | 79 |
| Preoperative Data | |
| Body mass index (kg/m2) | 28.8 ± 4.9 |
| History of diabetes (Types I and II) (%) | 28.5 |
| aHistory of peripheral vascular disease (%) | 9.7 |
| bHistory of chronic inflammation (%) | 16.8 |
| Current smoker (%) | 9.3 |
| cPreoperative CRP level (mg/L) | 1.2 [0.6–2.8] |
| Preoperative creatinine (mg/dL) | 1.09 ± 0.30 |
| Preoperative Medications | |
| dPreoperative steroid use (%) | 2.0 |
| Duration of statin use prior to CABG (%) | |
| No statin use | 23.1 |
| <1 month | 11.1 |
| 1–6 months | 8.3 |
| ≥ 6 months | 43.6 |
| Unknown | 13.9 |
| Last statin dose administered prior to CABG (%) | |
| <24 hours | 62.1 |
| 24–72 hours | 5.4 |
| ≥ 72 hours | 1.3 |
| Unknown | 8.1 |
| Preoperative aspirin use (%) | 76.3 |
| Intraoperative Data | |
| eBlood product transfusion (%) | 56.3 |
| Aortic cross clamp time (min) | 73 ± 34 |
| Cardiopulmonary bypass time (min) | 98 ± 43 |
| Number of coronary grafts (%) | |
| 1 | 2.8 |
| 2 | 13.8 |
| 3 | 44.9 |
| ≥ 4 | 38.5 |
*Continuous data are expressed as mean ± SD. aPeripheral vascular disease was defined as vascular disease of the upper or lower extremities, or thoracic or abdominal aorta by patient history. bChronic inflammation disease of the bowel, joints or skin by patient history. cCRP level expressed in median mg/L with 25th and 75th percentiles.dSteroids given by any route within the last month. eBlood product of any kind given intraoperatively through postoperative day 2.